Andrew Keller, MD
Radiation Oncology · Orlando, FLNPI 1184154973
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $584, more than ten times the $33 reported in 2019.
Across 38 payments — averaging $42.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$361
- Bioprotect Medical, Inc.$176
- Novocure Inc.$166
- Elekta, Inc.$134
- Boston Scientific$110
- Brainlab, Inc.$100
- plus $563 from 16 others
What the payments were for
- Food & beverage$1,610100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 5 | $361 |
| Bioprotect Medical, Inc. | 3 | $176 |
| Novocure Inc. | 3 | $166 |
| Elekta, Inc. | 1 | $134 |
| Boston Scientific | 4 | $110 |
| Brainlab, Inc. | 1 | $100 |
| AstraZeneca | 4 | $93 |
| Monteris Medical Corporation | 1 | $74 |
| Tersera Therapeutics LLC | 2 | $49 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Stryker | 1 | $32 |
| Eisai Inc. | 1 | $30 |
| Blue Earth Diagnostics | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Bayer | 1 | $27 |
| Coherus Oncology, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Progenics Pharmaceuticals, Inc. | 1 | $25 |
| Telix Pharmaceuticals | 1 | $23 |
| Novartis | 1 | $21 |
| Merck | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,610 in reported general payments places this provider in the 65th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Orlando
- Shravan KandulaOrlando$444K
- Ravi ShridharOrlando$192K
- Akash NandaOrlando$165K
- Imran MohiuddinOrlando$93K
- Charles HodgeOrlando$34K
- Bridget KoontzOrlando$26K
- Justin RineerOrlando$11K
- Matthew BiagioliOrlando$10K
- Shiv DesaiOrlando$8K
- Nina JohnsonOrlando$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.